{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:04:26Z","timestamp":1766167466137,"version":"3.48.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03392-3","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T05:14:35Z","timestamp":1737695675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The clinical effects and mechanism of action of ranibizumab in treating myopic choroidal neovascularization"],"prefix":"10.1007","volume":"45","author":[{"given":"Wenting","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1105-2496","authenticated-orcid":false,"given":"Yonghui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"3392_CR1","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/s0161-6420(82)34677-1","volume":"89","author":"KG Noble","year":"1982","unstructured":"Noble KG, Carr RE (1982) Pathologic myopia. Ophthalmology 89:1099\u20131100. https:\/\/doi.org\/10.1016\/s0161-6420(82)34677-1","journal-title":"Ophthalmology"},{"issue":"1","key":"3392_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12886-020-01554-2","volume":"20","author":"RP Finger","year":"2020","unstructured":"Finger RP, Daien V, Eldem BM et al (2020) Anti-vascular endothelial growth factor in neovascular age-related macular degeneration: a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems. BMC Ophthalmol 20(1):294. https:\/\/doi.org\/10.1186\/s12886-020-01554-2","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"3392_CR3","doi-asserted-by":"publisher","first-page":"M20","DOI":"10.1167\/iovs.18-25957","volume":"60","author":"DI Flitcroft","year":"2019","unstructured":"Flitcroft DI, He M, Jonas JB et al (2019) IMI\u2014defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci 60(3):M20\u2013M30. https:\/\/doi.org\/10.1167\/iovs.18-25957","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"3392_CR4","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/S0161-6420(03)00461-5","volume":"110","author":"T Yoshida","year":"2023","unstructured":"Yoshida T, Ohno-Matsui K, Yasuzumi K et al (2023) Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 110(7):1297\u20131305. https:\/\/doi.org\/10.1016\/S0161-6420(03)00461-5","journal-title":"Ophthalmology"},{"issue":"7","key":"3392_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/iovs.62.5.5","volume":"62","author":"K Ohno-Matsui","year":"2021","unstructured":"Ohno-Matsui K, Wu PC, Yamashiro K et al (2021) IMI pathologic myopia. Invest Ophthalmol Vis Sci 62(7):17. https:\/\/doi.org\/10.1167\/iovs.62.5.5","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3392_CR6","first-page":"849","volume":"43","author":"AN Witmer","year":"2002","unstructured":"Witmer AN, Blaauwgeers HG, Weich HA et al (2002) Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest Ophthalmol Vis Sci 43(3):849\u2013857","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3392_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-022-01277-4","volume":"8","author":"SB Wang","year":"2023","unstructured":"Wang SB, Nagasaka Y, Argyle D et al (2023) Targeting the m6A mRNA demethylase FTO suppresses vascular endothelial growth factor release and choroidal neovascularization. Signal Transduct Target Ther 8(1):72. https:\/\/doi.org\/10.1038\/s41392-022-01277-4","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"3392_CR8","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1006\/jmbi.1999.3192","volume":"293","author":"Y Chen","year":"1999","unstructured":"Chen Y, Wiesmann C, Fuh G et al (1999) Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinitymatured Fab in complex with antigen. Mol Biol 293(4):865\u2013881. https:\/\/doi.org\/10.1006\/jmbi.1999.3192","journal-title":"Mol Biol"},{"issue":"11","key":"3392_CR9","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1097\/IAE.0000000000003869","volume":"43","author":"R Sakata","year":"2023","unstructured":"Sakata R, Miyata M, Ooto S et al (2023) Ten-year visual outcome and change in chorioretinal atrophy after intravitreal ranibizumab for macular neovascularization in pathologic myopia. Retina 43(11):1863\u20131871. https:\/\/doi.org\/10.1097\/IAE.0000000000003869","journal-title":"Retina"},{"issue":"1","key":"3392_CR10","doi-asserted-by":"publisher","first-page":"e0227557","DOI":"10.1371\/journal.pone.0227557","volume":"15","author":"RD Hamilton","year":"2020","unstructured":"Hamilton RD, Clemens A, Minnella AM et al (2020) Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: results from the luminous study. PLoS ONE 15(1):e0227557. https:\/\/doi.org\/10.1371\/journal.pone.0227557","journal-title":"PLoS ONE"},{"issue":"5","key":"3392_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1755-3768.2012.02414.x","volume":"90","author":"JB Jonas","year":"2012","unstructured":"Jonas JB, Tao Y, Neumaier M et al (2012) Cytokine concentration in aqueous humour of eyes with exudative age-related macular degeneration. Acta Ophthalmol 90(5):381\u2013388. https:\/\/doi.org\/10.1111\/j.1755-3768.2012.02414.x","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"3392_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s10020-023-00674-x","volume":"29","author":"W Lei","year":"2023","unstructured":"Lei W, Xu H, Yao H et al (2023) 5\u03b1-hydroxycostic acid inhibits choroidal neovascularization in rats through a dual signalling pathway mediated by VEGF and angiopoietin 2. Mol Med 29(1):151. https:\/\/doi.org\/10.1186\/s10020-023-00674-x","journal-title":"Mol Med"},{"issue":"6","key":"3392_CR13","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1076\/ceyr.21.6.952.6992","volume":"21","author":"T Yasukawa","year":"2000","unstructured":"Yasukawa T, Kimura H, Tabata Y et al (2000) Active drug targeting with immunoconjugates to choroidal neovascularization. Curr Eye Res 21(6):952\u2013961. https:\/\/doi.org\/10.1076\/ceyr.21.6.952.6992","journal-title":"Curr Eye Res"},{"key":"3392_CR14","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.2147\/DDDT.S307657","volume":"15","author":"T Sun","year":"2021","unstructured":"Sun T, Wei Q, Gao P, Zhang Y, Peng Q (2021) Cytokine and chemokine profile changes in patients with neovascular age-related macular degeneration after intravitreal ranibizumab injection for choroidal neovascularization. Drug Des Devel Ther 15:2457\u20132467. https:\/\/doi.org\/10.2147\/DDDT.S307657","journal-title":"Drug Des Devel Ther"},{"key":"3392_CR15","doi-asserted-by":"publisher","first-page":"108471","DOI":"10.1016\/j.exer.2021.108471","volume":"204","author":"P Yang","year":"2021","unstructured":"Yang P, Neal SE, Buehne KL et al (2021) Complement-mediated release of fibroblast growth factor 2 from human RPE cells. Exp Eye Res 204:108471. https:\/\/doi.org\/10.1016\/j.exer.2021.108471","journal-title":"Exp Eye Res"},{"issue":"3","key":"3392_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.55133\/eji.290307","volume":"29","author":"SA Abou Shousha","year":"2022","unstructured":"Abou Shousha SA, Hussein B, Shahine Y et al (2022) Angiogenic activities of interleukin-8, vascular endothelial growth factor and matrix metalloproteinase-9 in breast cancer. Egypt J Immunol 29(3):54\u201363","journal-title":"Egypt J Immunol"},{"issue":"4","key":"3392_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1096\/fba.2019-00074","volume":"2","author":"VE Lorenc","year":"2020","unstructured":"Lorenc VE, Lima E Silva R, Hackett SF et al (2020) Hepatocyte growth factor is upregulated in ischemic retina and contributes to retinal vascular leakage and neovascularization. FASEB Bioadv 2(4):219\u2013233. https:\/\/doi.org\/10.1096\/fba.2019-00074","journal-title":"FASEB Bioadv"},{"key":"3392_CR18","doi-asserted-by":"publisher","first-page":"108624","DOI":"10.1016\/j.exer.2021.108624","volume":"208","author":"J Gu","year":"2021","unstructured":"Gu J, Qiu Z, Li L et al (2021) Geniposide alleviates choroidal neovascularization by downregulating HB-EGF release from RPE cells by downregulating the miR-145-5p\/NF-\u03baB axis. Exp Eye Res 208:108624. https:\/\/doi.org\/10.1016\/j.exer.2021.108624","journal-title":"Exp Eye Res"},{"key":"3392_CR19","doi-asserted-by":"publisher","first-page":"107748","DOI":"10.1016\/j.exer.2019.107748","volume":"187","author":"L Ma","year":"2019","unstructured":"Ma L, Ng TK, Chen H et al (2019) Identification and characterization of a novel promoter variant in placental growth factor for neovascular age-related macular degeneration. Exp Eye Res 187:107748. https:\/\/doi.org\/10.1016\/j.exer.2019.107748","journal-title":"Exp Eye Res"},{"key":"3392_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.exer.2018.05.030","volume":"174","author":"JF Zhao","year":"2018","unstructured":"Zhao JF, Hua HR, Chen QB et al (2018) Impact of fenofibrate on choroidal neovascularization formation and VEGF-C plus VEGFR-3 in Brown Norway rats. Exp Eye Res 174:152\u2013160. https:\/\/doi.org\/10.1016\/j.exer.2018.05.030","journal-title":"Exp Eye Res"},{"issue":"7","key":"3392_CR21","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1161\/ATVBAHA.111.225961","volume":"31","author":"S Jauhiainen","year":"2011","unstructured":"Jauhiainen S, H\u00e4kkinen SK, Toivanen PI et al (2011) Vascular endothelial growth factor (VEGF)-D stimulates VEGF-A, stanniocalcin-1 and neuropilin-2 and has potent angiogenic effects. Arterioscler Thromb Vasc Biol 31(7):1617\u20131624. https:\/\/doi.org\/10.1161\/ATVBAHA.111.225961","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3392_CR22","doi-asserted-by":"publisher","first-page":"108446","DOI":"10.1016\/j.exer.2021.108446","volume":"204","author":"Y Liu","year":"2021","unstructured":"Liu Y, Feng M, Cai J et al (2021) Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling. Exp Eye Res 204:108446. https:\/\/doi.org\/10.1016\/j.exer.2021.108446","journal-title":"Exp Eye Res"},{"issue":"8","key":"3392_CR23","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2147\/OPTH.S61871","volume":"19","author":"H Gungel","year":"2014","unstructured":"Gungel H, Osmanbasoglu OA, Altan C et al (2014) The effects of ranibizumab injections on fluorescein angiographic findings and visual acuity recovery in age-related macular degeneration. Clin Ophthalmol 19(8):981\u2013988. https:\/\/doi.org\/10.2147\/OPTH.S61871","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"3392_CR24","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1111\/j.1755-3768.2011.02240.x","volume":"90","author":"AM Carneiro","year":"2012","unstructured":"Carneiro AM, Costa R, Falcao MS et al (2012) Vascular endothelial growth factor plasma contents before and after treatment of neovascular age-related macular degeneration with bevacizumab or ranibizumab. Acta Ophthalmol 90(1):e25-30. https:\/\/doi.org\/10.1111\/j.1755-3768.2011.02240.x","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"3392_CR25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ajo.2005.10.012","volume":"141","author":"JP Tong","year":"2006","unstructured":"Tong JP, Chan WM, Liu DT et al (2006) Aqueous humor contents of vascular endothelial growth factor and pigment epitheliumderived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 141(3):456\u2013462. https:\/\/doi.org\/10.1016\/j.ajo.2005.10.012","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"3392_CR26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1755-3768.2009.01717.x","volume":"89","author":"O Sawada","year":"2011","unstructured":"Sawada O, Kawamura H, Kakinoki M et al (2011) Vascular endothelial growth factor in the aqueous humour in eyes with myopic choroidal neovascularization. Acta Ophthalmol 89(5):459\u2013462. https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01717.x","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"3392_CR27","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/s0021-5155(02)00536-1","volume":"46","author":"R Yamanaka","year":"2002","unstructured":"Yamanaka R, Ogata N, Yamamoto C et al (2002) Expression of transforming growth factor-beta receptors in normal rat retina and experimental choroidal neovascularization. Jpn J Ophthalmol 46(5):525\u2013532. https:\/\/doi.org\/10.1016\/s0021-5155(02)00536-1","journal-title":"Jpn J Ophthalmol"},{"key":"3392_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijbiomac.2021.02.218","volume":"180","author":"S Yoodee","year":"2021","unstructured":"Yoodee S, Peerapen P, Plumworasawat S, Thongboonkerd V (2021) ARID1A knockdown in human endothelial cells directly induces angiogenesis by regulating angiopoietin-2 secretion and endothelial cell activity. Int J Biol Macromol 180:1\u201313. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.02.218","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"3392_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s004170050081","volume":"236","author":"M Miyashiro","year":"1998","unstructured":"Miyashiro M, Ogata N, Takahashi K et al (1998) Expression of basic fibroblast growth factor and its receptor mRNA in retinal tissue following ischemic injury in the rat. Graefes Arch Clin Exp Ophthalmol 236(4):295\u2013300. https:\/\/doi.org\/10.1007\/s004170050081","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"3392_CR30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00417-009-1058-x","volume":"247","author":"A Stahl","year":"2009","unstructured":"Stahl A, Paschek L, Martin G et al (2009) Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis. Graefes Arch Clin Exp Ophthalmol 247(6):767\u2013773. https:\/\/doi.org\/10.1007\/s00417-009-1058-x","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"3392_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1167\/iovs.16-20967","volume":"58","author":"M Hata","year":"2017","unstructured":"Hata M, Yamashiro K, Ooto S et al (2017) Intraocular vascular endothelial growth factor contents in pachychoroid neovasculopathy and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 58(1):292\u2013298. https:\/\/doi.org\/10.1167\/iovs.16-20967","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3392_CR32","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.exer.2006.05.007","volume":"83","author":"Y Ikeda","year":"2006","unstructured":"Ikeda Y, Yonemitsu Y, Onimaru M et al (2006) The regulation of vascular endothelial growth factors(VEGF-A, -C, and -D) expression in the retinal pigment epithelium. Exp Eye Res 83(5):1031\u20131040. https:\/\/doi.org\/10.1016\/j.exer.2006.05.007","journal-title":"Exp Eye Res"},{"issue":"7","key":"3392_CR33","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1161\/ATVBAHA.111.225961","volume":"31","author":"S Jauhiainen","year":"2011","unstructured":"Jauhiainen S, H\u00e4kkinen SK, Toivanen PI et al (2011) Vascular endothelial growth factor(VEGF)-D stimulates VEGF-A, stanniocalcin-1, and neuropilin-2 and has potent angiogenic effects. Arterioscler Thromb Vasc Biol 31(7):1617\u20131624. https:\/\/doi.org\/10.1161\/ATVBAHA.111.225961","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"3392_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000510778","volume":"65","author":"F Yang","year":"2022","unstructured":"Yang F, Sun Y, Bai Y, Li S, Huang L, Li X (2022) Asthma promotes choroidal neovascularization via the transforming growth factor Beta1\/Smad signalling pathway in a mouse model. Ophthalmic Res 65(1):14\u201329. https:\/\/doi.org\/10.1159\/000510778","journal-title":"Ophthalmic Res"},{"key":"3392_CR35","doi-asserted-by":"publisher","first-page":"638098","DOI":"10.3389\/fncel.2021.638098","volume":"15","author":"J Kim","year":"2021","unstructured":"Kim J, Kim JH, Do JY et al (2021) Key role of microglial matrix metalloproteinases in choroidal neovascularization. Front Cell Neurosci 15:638098","journal-title":"Front Cell Neurosci"},{"key":"3392_CR36","first-page":"622","volume":"27","author":"S Hagbi-Levi","year":"2021","unstructured":"Hagbi-Levi S, Tiosano L, Rinsky B et al (2021) Anti-tumor necrosis factor alpha reduces the proangiogenic effects of activated macrophages derived from patients with age-related macular degeneration. Mol Vis 27:622\u2013631","journal-title":"Mol Vis"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03392-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03392-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03392-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:02:22Z","timestamp":1766167342000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03392-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3392"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03392-3","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study. This article does not contain any studies with animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"33"}}